Post-Market Intelligence

FDA PreCheck Initiative Draws Strong Industry Reaction at Recent Stakeholder Meeting

Biologics Inspection Case Studies Highlight API and Drug Product Deficiencies

Enforcement

FDA Inspection Shows Systemic Data Falsification Issues

Conference Spotlight

49 New FDA 483s Added | November 12th 2018